Inventor · disambiguated record
Nikhilesh N. Singh
Also filed as: SINGH NIKHILESH · SINGH NIKHILESH N · SINGH NIKHILESH NIHALA
13 granted patents·37 pending applications·398 citations·filing 1990–2023
93Inventor score
Files withSINGH NIKHILESH N21ORPHOMED INC6TRANSCEPT PHARMACEUTICALS INC5PARATEK PHARM INNC3SATSUMA PHARMACEUTICALS INC3
Top patents by PatentIndex Score
50 records- 0194US7682628B2Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereofTRANSCEPT PHARMACEUTICALS INC·Filed 2007·Granted Mar 23, 2010·37 cites·17 claims
- 0293US5458879AOral vehicle compositionsPROCTER & GAMBLE·Filed 1994·Granted Oct 17, 1995·257 cites·10 claims
- 0392US7658945B2Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereofTRANSCEPT PHARMACEUTICALS INC·Filed 2005·Granted Feb 9, 2010·26 cites·26 claims
- 0490US9321780B2Buprenorphine dimer and its use in treatment of gastrointestinal disordersOrphoMed LLC·Filed 2015·Granted Apr 26, 2016·8 cites·9 claims
- 0590US9309256B2Pharmaceutically active dimers linked through phenolic hydroxyl groupsOrphoMed LLC·Filed 2015·Granted Apr 12, 2016·8 cites·10 claims
- 0688US9549924B2Use of buprenorphine dimer in the treatment of peripheral neuropathic painORPHOMED INC·Filed 2015·Granted Jan 24, 2017·6 cites·9 claims
- 0787US9480665B2Methods of treating pain or fever using pharmaceutically active acetaminophen dimers linked through phenolic hydroxyl groupsORPHOMED INC·Filed 2015·Granted Nov 1, 2016·5 cites·13 claims
- 0876US9782369B2Method of treating pain using an acetaminophen dimer ether-linked through phenolic hydroxyl groupsORPHOMED INC·Filed 2016·Granted Oct 10, 2017·1 cites·6 claims
- 0976US8252809B2Compositions for treating insomniaSINGH NIKHILESH N·Filed 2010·Granted Aug 28, 2012·2 cites·26 claims
- 1076US2024108619A1Intranasal dhe for the treatment of headacheSATSUMA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1175US9732096B2Buprenorphine dimer and its use in treatment of gastrointestinal disordersORPHOMED INC·Filed 2016·Granted Aug 15, 2017·1 cites·6 claims
- 1275US8242131B2Methods of treating middle-of-the-night insomniaSINGH NIKHILESH·Filed 2006·Granted Aug 14, 2012·2 cites·25 claims
- 1372US5175152AComposition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor formSINGH NIKHILESH N·Filed 1990·Granted Dec 29, 1992·45 cites·21 claims
- 1470US2008004260A1Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditionsTRANSCEPT PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1570US2008004291A1Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditionsSINGH NIKHILESH N·Filed 2007·Application pending·0 cites
- 1664US2015352084A1Compositions and methods for treating middle-of-the-night insomniaPARATEK PHARM INNC·Filed 2014·Application pending·0 cites
- 1762US2007225322A1Compositions and methods for treating middle-of-the night insomniaTRANSORAL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1862US2012196877A1Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditionsSINGH NIKHILESH N·Filed 2011·Application pending·0 cites
- 1962US2015290177A1Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereofSINGH NIKHILESH N·Filed 2014·Application pending·0 cites
- 2061US2011046117A1Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditionsSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 2161US2018078534A1Compositions and methods for treating middle-of-the-night insomniaPARATEK PHARM INNC·Filed 2017·Application pending·0 cites
- 2261US2008057119A1Compositions and methods for treating middle-of-the night insomniaSINGH NIKHILESH N·Filed 2007·Application pending·0 cites
- 2361US2020179379A1Intranasal dhe for the treatment of headacheSATSUMA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2460US11236067B2Compound for treating cystic fibrosisORPHOMED INC·Filed 2020·Granted Feb 1, 2022·0 cites·14 claims
- 2560US2007287740A1Compositions and methods of treating middle-of-the night insomniaTRANSCEPT PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2659US2010113483A1Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditionsSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 2758US2008213363A1Methods and compositions for delivering 5-HT3 antagonists across the oral mucosaSINGH NIKHILESH N·Filed 2004·Application pending·0 cites
- 2858US2013210856A1Compositions and methods for treating sleep disordersSINGH NIKHILESH N·Filed 2012·Application pending·0 cites
- 2957US2017065517A1Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereofPARATEK PHARM INNC·Filed 2016·Application pending·0 cites
- 3057US2019275036A1Intranasal DHE for the Treatment of HeadacheSATSUMA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3157US2016228433A1Intranasal dhe for the treatment of headacheSHIN NIPPON BIOMEDICAL LABORATORIES LTD·Filed 2014·Application pending·0 cites
- 3257US2012328533A1Hypnotic compositions and methods of use thereofSINGH NIKHILESH N·Filed 2012·Application pending·0 cites
- 3356US2008132535A1Stabilized Zolpidem Pharmaceutical CompositionsTRANSCEPT PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3455US2011112116A1Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditionsSINGH NIKHILESH N·Filed 2011·Application pending·0 cites
- 3555US2008254101A1Pilocarpine compositions and methods of use thereofSINGH NIKHILESH N·Filed 2008·Application pending·0 cites
- 3654US2011039881A1Compositions and methods for treating middle-of-the-night insomniaSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 3753US2012071464A1Method of treatment of obsessive compulsive disorder with ondansetronSINGH NIKHILESH N·Filed 2011·Application pending·0 cites
- 3853US2010113427A1Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditionsSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 3952US2010291004A1Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereofSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 4051US2005042281A1Compositions for delivering therapeutic agents across the oral mucosaFiled 2003·Application pending·0 cites
- 4150US2010256210A1Methods and compositions for delivering 5-ht3 antagonists across the oral mucosaSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 4250US2010298397A1Method of treatment of obsessive compulsive disorder with ondansetronSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 4349US2006029665A1Pilocarpine compositions and methods of use thereofTRANSORAL PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 4448US2003185884A1Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpineFiled 2002·Application pending·0 cites
- 4546US2012034300A1Stabilized zolpidem pharmaceutical compositionsSINGH NIKHILESH N·Filed 2011·Application pending·0 cites
- 4646US2007059254A1Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereofTRANSORAL PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 4745US2010249178A1Compositions and methods for treating middle-of-the-night insomniaSINGH NIKHILESH·Filed 2010·Application pending·0 cites
- 4844US2010240695A1Stabilized zolpidem pharmaceutical compositionsSINGH NIKHILESH N·Filed 2010·Application pending·0 cites
- 4938US2018305370A1Ethylene glycol ether of buprenorphineORPHOMED INC·Filed 2016·Application pending·0 cites
- 5034US2012302616A1Method of treatment of obsessive compulsive disorder with ondansetronSINGH NIKHILESH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nikhilesh N. Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →